Evidence map›Paper›PMID 30683699›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

Insertion of N-Terminal Hinge Glycosylation Enhances Interactions of the Fc Region of Human IgG1 Monomers with Glycan-Dependent Receptors and Blocks Hemagglutination by the Influenza Virus.

Patricia A Blundell, Dongli Lu, Mark Wilkinson, Anne Dell, Stuart Haslam, Richard J Pleass

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Patricia A BlundellDepartment of Parasitology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, United Kingdom; and.
Dongli LuDepartment of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom.
Mark WilkinsonDepartment of Parasitology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, United Kingdom; and.
Anne DellDepartment of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom.
Stuart HaslamDepartment of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom.ORCID 0000-0002-5563-679X
Richard J PleassDepartment of Parasitology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, United Kingdom; and richard.pleass@lstmed.ac.uk.ORCID 0000-0001-7438-8296
Imperial College London · GBLiverpool School of Tropical Medicine · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F008309/1Biotechnology and Biological Sciences Research Council BBF0083091Medical Research Council MC_PC_12017Medical Research Council MC_PC_16078Medical Research Council MC_PC_17167Wellcome Trust 097830/Z/11/ZWellcome Trust 109469Wellcome Trust 208938/Z/17/Z
6 · The paper itself

Abstract

In therapeutic applications in which the Fc of IgG is critically important, the receptor binding and functional properties of the Fc are lost after deglycosylation or removal of the unique Asn

Indexed as

GlycosylationHemagglutinationHumansImmunoglobulin Fc FragmentsImmunoglobulin GMutationOrthomyxoviridaePolysaccharidesReceptors, IgGImmunoglobulin Fc FragmentsImmunoglobulin GPolysaccharidesReceptors, IgG

Identifiers

PMID30683699
PMCPMC6379808
OpenAlexW2912885282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.